Robin Cornelissen
- Pulmonary and Respiratory Medicine top 2%
- Oncology top 5%
- Immunology top 10%
- Molecular Biology
- Cancer Research top 10%
- Co-authors
- Joachim G.J.V. AertsJoost P. HegmansLysanne A. LievenseRudi W. HendriksKoen BezemerHenk C. HoogstedenAlexander P.W.M. MaatDaphne W. Dumoulin
- Topics
- Occupational and environmental lung diseases (41 papers)Lung Cancer Treatments and Mutations (28 papers)Cancer Immunotherapy and Biomarkers (27 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- NetherlandsUnited StatesItaly
In The Last Decade
Robin Cornelissen
92 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Pulmonary and Respiratory Medicine 1.3k
- Oncology 938
- Immunology 293
- Molecular Biology 218
- Cancer Research 176
Countries citing papers authored by Robin Cornelissen
This map shows the geographic impact of Robin Cornelissen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Cornelissen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Cornelissen more than expected).
Fields of papers citing papers by Robin Cornelissen
This network shows the impact of papers produced by Robin Cornelissen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Cornelissen. The network helps show where Robin Cornelissen may publish in the future.
Co-authorship network of co-authors of Robin Cornelissen
This figure shows the co-authorship network connecting the top 25 collaborators of Robin Cornelissen. A scholar is included among the top collaborators of Robin Cornelissen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Cornelissen. Robin Cornelissen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 13 | |
| 5 | 34 | |
| 6 | LBA1 CheckMate 77T: Phase III study comparing neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) vs neoadjuvant placebo plus chemo followed by surgery and adjuvant NIVO or placebo for previously untreated, resectable stage II–IIIb NSCLCbreakdown → | 67 |
| 7 | 34 | |
| 8 | 10 | |
| 9 | 38 | |
| 10 | 5 | |
| 11 | 14 | |
| 12 | 6 | |
| 13 | 23 | |
| 14 | 20 | |
| 15 | 37 | |
| 16 | 2 | |
| 17 | 71 | |
| 18 | 54 | |
| 19 | 15 | |
| 20 | 83 |
About Robin Cornelissen
Robin Cornelissen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Biotechnology, having authored 98 papers that have together received 1.9k indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (41 papers), Lung Cancer Treatments and Mutations (28 papers) and Cancer Immunotherapy and Biomarkers (27 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.3k citations), Oncology (938 citations) and Biotechnology (158 citations). Robin Cornelissen has collaborated with scholars based in Netherlands, United States and Italy. Frequent co-authors include Joachim G.J.V. Aerts, Joost P. Hegmans, Lysanne A. Lievense, Rudi W. Hendriks, Koen Bezemer, Henk C. Hoogsteden, Alexander P.W.M. Maat, Daphne W. Dumoulin, Margaretha E.H. Kaijen-Lambers and Paul Baas. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.